Global Equity Strategy U.S. Fed Cut, Now What?
With further consolidation likely for the broad indexes, we want to stick with areas of the market that have shown an ability to outperform despite...
435 Views
IPCA Laboratories- 2QFY19 Results – Growing While Awaiting USFDA Approvals
Ipca Laboratories (IPCA IN) 2QFY19 PAT of Rs 1,197 mn beat our estimates of Rs 1,023 mn. EBITDA margins, excluding forex loss, stood at 20.4%,...
416 Views
IPCA Labs: 1QFY19 Result - International Sales Decline but EBITDA Margins Improve
Ipca Laboratories (IPCA IN) reported revenue growth of 20% YoY at Rs. 8,427 mn, EBITDA at Rs. 1,140 mn and PAT at Rs. 655 mn in 1QFY19 led by low...
287 Views
Global Strategy: Carnage Continuation Amid Turkey Turmoil and US Dollar Breakout
Corrections across global ex-US markets continue to limit attractive investment opportunities from both a price and relative strength perspective. ...
495 Views
IPCA: Annual Report FY18: Normal Service to Resume
Ipca Laboratories (IPCA IN)'s FY18 revenue grew ~2.5% YoY to Rs. 32,587 mn. EBITDA stood at Rs. 4,812 mn (6.3% YoY growth), with the margins of...
462 Views